Effects of Estrogen Receptor and Wnt Signaling Activation on Mechanically Induced Bone Formation in a Mouse Model of Postmenopausal Bone Loss.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Nov 2020
Historique:
received: 14 09 2020
revised: 30 10 2020
accepted: 31 10 2020
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 17 3 2021
Statut: epublish

Résumé

In the adult skeleton, bone remodeling is required to replace damaged bone and functionally adapt bone mass and structure according to the mechanical requirements. It is regulated by multiple endocrine and paracrine factors, including hormones and growth factors, which interact in a coordinated manner. Because the response of bone to mechanical signals is dependent on functional estrogen receptor (ER) and Wnt/β-catenin signaling and is impaired in postmenopausal osteoporosis by estrogen deficiency, it is of paramount importance to elucidate the underlying mechanisms as a basis for the development of new strategies in the treatment of osteoporosis. The present study aimed to investigate the effectiveness of the activation of the ligand-dependent ER and the Wnt/β-catenin signal transduction pathways on mechanically induced bone formation using ovariectomized mice as a model of postmenopausal bone loss. We demonstrated that both pathways interact in the regulation of bone mass adaption in response to mechanical loading and that the activation of Wnt/β-catenin signaling considerably increased mechanically induced bone formation, whereas the effects of estrogen treatment strictly depended on the estrogen status in the mice.

Identifiants

pubmed: 33167497
pii: ijms21218301
doi: 10.3390/ijms21218301
pmc: PMC7663944
pii:
doi:

Substances chimiques

Estrogens 0
Receptors, Estrogen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : German Research Foundation
ID : IG 18/15-2
Organisme : German Research Foundation
ID : HA 8470/1-1

Références

Bone. 2018 May;110:11-20
pubmed: 29367057
Nat Rev Endocrinol. 2011 Aug 16;7(12):715-26
pubmed: 21844907
J Bone Miner Res. 1987 Dec;2(6):595-610
pubmed: 3455637
Bone. 2013 May;54(1):35-43
pubmed: 23356985
Endocrinology. 2012 May;153(5):2254-66
pubmed: 22416084
PLoS One. 2009;4(4):e5153
pubmed: 19360103
Angle Orthod. 2004 Feb;74(1):3-15
pubmed: 15038485
Steroids. 2003 Jan;68(1):1-9
pubmed: 12475718
J Biol Chem. 2006 Apr 7;281(14):9576-88
pubmed: 16461770
Trends Endocrinol Metab. 2012 Nov;23(11):576-81
pubmed: 22595550
Nature. 2003 Jul 24;424(6947):389
pubmed: 12879058
J Bone Miner Res. 2005 Dec;20(12):2150-8
pubmed: 16294268
Endocrinology. 2010 Dec;151(12):5582-90
pubmed: 20943807
J Biol Chem. 2002 Jun 28;277(26):23934-41
pubmed: 11960980
J Bone Miner Res. 2013 Jan;28(1):2-17
pubmed: 23197339
Nature. 2003 May 15;423(6937):349-55
pubmed: 12748654
Physiol Rev. 2007 Jul;87(3):905-31
pubmed: 17615392
J Cell Biochem. 2015 Jul;116(7):1419-30
pubmed: 25676585
J Bone Miner Res. 2013 Feb;28(2):291-301
pubmed: 22972752
Development. 2006 Aug;133(16):3231-44
pubmed: 16854976
Cold Spring Harb Perspect Biol. 2012 Dec 01;4(12):
pubmed: 23209148
Dis Model Mech. 2015 Jan;8(1):93-104
pubmed: 25381012
J Bone Miner Res. 2001 Jun;16(6):1045-55
pubmed: 11393781
J Biol Chem. 2007 Jul 13;282(28):20715-27
pubmed: 17491024
J Clin Invest. 2013 Jan;123(1):394-404
pubmed: 23221342
Am J Hum Genet. 2002 Jan;70(1):11-9
pubmed: 11741193
Nat Med. 2013 Feb;19(2):179-92
pubmed: 23389618
Cell. 2001 Nov 16;107(4):513-23
pubmed: 11719191
Endocrinology. 2006 Jun;147(6):3027-39
pubmed: 16497810
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2678-2684
pubmed: 30093109
Biochem Biophys Res Commun. 2010 Apr 9;394(3):755-9
pubmed: 20227388
Bone. 2000 Aug;27(2):233-9
pubmed: 10913916
Bone. 2011 Apr 1;48(4):945-51
pubmed: 21185956
J Theor Biol. 1984 Mar 21;107(2):321-7
pubmed: 6717041
Ann N Y Acad Sci. 2006 Dec;1092:385-96
pubmed: 17308163
Endocr Rev. 2002 Jun;23(3):279-302
pubmed: 12050121
J Bone Miner Res. 1993 Mar;8(3):347-57
pubmed: 8456589
J Bone Miner Res. 2014 Mar;29(3):705-15
pubmed: 23929793
J Bone Miner Res. 2001 Nov;16(11):1937-47
pubmed: 11697789
Bone. 2002 Sep;31(3):407-12
pubmed: 12231414
Br J Pharmacol. 2016 Jul;173(14):2237-49
pubmed: 27111560
Nat Rev Endocrinol. 2013 Dec;9(12):699-712
pubmed: 24042328
J Bone Miner Res. 2006 Aug;21(8):1297-306
pubmed: 16869728
J Bone Miner Res. 1996 Apr;11(4):502-11
pubmed: 8992881
Bone. 1999 Jul;25(1):107-8
pubmed: 10423032
J Cell Biochem. 1996 Jun 15;61(4):609-18
pubmed: 8806085

Auteurs

Astrid Liedert (A)

Institute of Orhopedic Research and Biomechanics, Trauma Research Center Ulm, University Medical Center Ulm, 89081 Ulm, Germany.

Claudia Nemitz (C)

Institute of Orhopedic Research and Biomechanics, Trauma Research Center Ulm, University Medical Center Ulm, 89081 Ulm, Germany.

Melanie Haffner-Luntzer (M)

Institute of Orhopedic Research and Biomechanics, Trauma Research Center Ulm, University Medical Center Ulm, 89081 Ulm, Germany.

Fabian Schick (F)

Institute of Orhopedic Research and Biomechanics, Trauma Research Center Ulm, University Medical Center Ulm, 89081 Ulm, Germany.

Franz Jakob (F)

Orthopaedic Center for Musculoskeletal Research, University of Würzburg, 97074 Würzburg, Germany.

Anita Ignatius (A)

Institute of Orhopedic Research and Biomechanics, Trauma Research Center Ulm, University Medical Center Ulm, 89081 Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH